Performance of two questionnaires to measure treatment adherence in patients with Type-2 Diabetes

被引:20
|
作者
Prado-Aguilar, Carlos A. [1 ,4 ]
Martinez, Yolanda V. [1 ]
Segovia-Bernal, Yolanda [2 ]
Reyes-Martinez, Rosendo [3 ]
Arias-Ulloa, Raul [4 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Hosp Gen Zona 1, Aguascalientes, Ags, Mexico
[2] Inst Mexicano Seguro Social, Unidad Med Ambulatoria, Aguascalientes, Ags, Mexico
[3] Inst Mexicano Seguro Social, Unidad Med Familiar, Aguascalientes, Ags, Mexico
[4] Univ Autonoma Aguascalientes, Depto Salud Publ, Aguascalientes, Ags, Mexico
来源
BMC PUBLIC HEALTH | 2009年 / 9卷
关键词
MEDICATION ADHERENCE; THERAPY;
D O I
10.1186/1471-2458-9-38
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Most valid methods to measure treatment adherence require time and resources, and they are not easily applied in highly demanding Primary Health Care Clinics (PHCC). The objective of this study was to determine sensitivity, specificity, predictive values, likelihood ratios, and post-test probabilities of two novel questionnaires as proxy measurements of treatment adherence in Type-2 diabetic patients. Methods: Two questionnaires were developed by a group of experts to identify the patient's medical prescription knowledge (knowledge) and their attitudes toward treatment adherence (attitudes) as proxy measurements of adherence. The questionnaires were completed by patients receiving care in PHCC pertaining to the Mexican Institute of Social Security in Aguascalientes (Mexico). Pill count was used as gold standard. Participants were selected randomly, and their oral hypoglycemic prescriptions were studied. The main outcome measures for each questionnaire were sensitivity, specificity, predictive values, likelihood ratios, and post-test probabilities, all as an independent questionnaire test and in a serial analysis. Results: Adherence prevalence was 27.0% using pill count. Knowledge questionnaire showed the highest sensitivity (68.1%) and negative predictive value (82.2%), the lowest negative likelihood ratio (0.58) and post-test probability for a negative result (0.16). Serial analysis showed the highest specificity (77.4%) and positive predictive value (40.1%) as well as the highest positive likelihood ratio (1.8) and post-test probability for a positive result (0.39). Conclusion: Medical Prescription Knowledge questionnaire showed the best performance as proxy measurement to identify non-adherence in type 2 diabetic patients regarding negative predictive value, negative likelihood ratio, and post-test probability for a negative result. However, Medical Prescription Knowledge questionnaire performance may change in contexts with higher adherence prevalence. Therefore, more research is needed before using this method in other contexts.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] ZINC AS A COADJUVANT IN TYPE-2 DIABETES TREATMENT
    Ruz, M.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 44 - 44
  • [32] DRUGS ON THE HORIZON FOR TREATMENT OF TYPE-2 DIABETES
    RACHMAN, J
    TURNER, RC
    DIABETIC MEDICINE, 1995, 12 (06) : 467 - 478
  • [33] An integrated medical treatment for type-2 diabetes
    Bocci, Velio
    Zanardi, Iacopo
    Huijberts, Maya S. P.
    Travagli, Valter
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2014, 8 (01) : 57 - 61
  • [34] New treatment strategies for type-2 diabetes?
    Halimi, S
    PRESSE MEDICALE, 2005, 34 (18): : 1287 - 1292
  • [35] Validation of an instrument to measure adherence to type 2 diabetes management
    Daniela Beatriz Muñoz-López
    Verónica Reyes Pérez
    Ma. Eugenia Garay-Sevilla
    Mónica del Carmen Preciado-Puga
    International Journal of Clinical Pharmacy, 2021, 43 : 595 - 603
  • [36] Validation of an instrument to measure adherence to type 2 diabetes management
    Munoz-Lopez, Daniela Beatriz
    Reyes Perez, Veronica
    Garay-Sevilla, Ma. Eugenia
    Preciado-Puga, Monica del Carmen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 595 - 603
  • [37] Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy
    Adhien, Prem
    van Dijk, Liset
    de Vegter, Marinke
    Westein, Marnix
    Nijpels, Giel
    Hugtenburg, Jacqueline G.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1113 - 1119
  • [38] Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital
    Alejandra Soto
    Ximena Avila
    Pia Cordova
    Pola Fernandez
    Mariela Lopez
    Lorenzo A. Villa
    Felipe Morales
    International Journal of Clinical Pharmacy, 2015, 37 : 734 - 738
  • [39] Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy
    Prem Adhien
    Liset van Dijk
    Marinke de Vegter
    Marnix Westein
    Giel Nijpels
    Jacqueline G. Hugtenburg
    International Journal of Clinical Pharmacy, 2013, 35 : 1113 - 1119
  • [40] Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital
    Soto, Alejandra
    Avila, Ximena
    Cordova, Pia
    Fernandez, Pola
    Lopez, Mariela
    Villa, Lorenzo A.
    Morales, Felipe
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 734 - 738